• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种列线图,以预测重症监护病房中脓毒症性心肌病的风险。

Development and validation of a nomogram to predict risk of septic cardiomyopathy in the intensive care unit.

机构信息

The 2nd Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, China.

出版信息

Sci Rep. 2024 Jun 19;14(1):14114. doi: 10.1038/s41598-024-64965-x.

DOI:10.1038/s41598-024-64965-x
PMID:38898142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11187202/
Abstract

The aim of this study was to develop a simple but effective nomogram to predict risk of septic cardiomyopathy (SCM) in the intensive care unit (ICU). We analyzed data from patients who were first admitted to the ICU for sepsis between 2008 and 2019 in the MIMIC-IV database, with no history of heart disease, and divided them into a training cohort and an internal validation cohort at a 7:3 ratio. SCM is defined as sepsis diagnosed in the absence of other cardiac diseases, with echocardiographic evidence of left (or right) ventricular systolic or diastolic dysfunction and a left ventricular ejection fraction (LVEF) of less than 50%. Variables were selected from the training cohort using the Least Absolute Shrinkage and Selection Operator (LASSO) regression to develop an early predictive model for septic cardiomyopathy. A nomogram was constructed using logistic regression analysis and its receiver operating characteristic (ROC) and calibration were evaluated in two cohorts. A total of 1562 patients participated in this study, with 1094 in the training cohort and 468 in the internal validation cohort. SCM occurred in 13.4% (147 individuals) in the training cohort, 16.0% (75 individuals) in the internal validation cohort. After adjusting for various confounding factors, we constructed a nomogram that includes SAPS II, Troponin T, CK-MB index, white blood cell count, and presence of atrial fibrillation. The area under the curve (AUC) for the training cohort was 0.804 (95% CI 0.764-0.844), and the Hosmer-Lemeshow test showed good calibration of the nomogram (P = 0.288). Our nomogram also exhibited good discriminative ability and calibration in the internal validation cohort. Our nomogram demonstrated good potential in identifying patients at increased risk of SCM in the ICU.

摘要

本研究旨在开发一种简单有效的列线图来预测重症监护病房(ICU)中脓毒症性心肌病(SCM)的风险。我们分析了 2008 年至 2019 年期间在 MIMIC-IV 数据库中首次因败血症入住 ICU 的患者的数据,这些患者没有心脏病史,按照 7:3 的比例将其分为训练队列和内部验证队列。SCM 的定义为在无其他心脏疾病的情况下诊断为败血症,伴有超声心动图左(或右)心室收缩或舒张功能障碍和左心室射血分数(LVEF)<50%的证据。使用最小绝对收缩和选择算子(LASSO)回归从训练队列中选择变量,以开发脓毒症性心肌病的早期预测模型。使用逻辑回归分析构建列线图,并在两个队列中评估其接收者操作特征(ROC)和校准。共有 1562 名患者参与了本研究,其中 1094 名在训练队列中,468 名在内部验证队列中。在训练队列中,SCM 的发生率为 13.4%(147 例),在内部验证队列中为 16.0%(75 例)。在调整了各种混杂因素后,我们构建了一个包含 SAPS II、肌钙蛋白 T、CK-MB 指数、白细胞计数和心房颤动的列线图。训练队列的曲线下面积(AUC)为 0.804(95%CI 0.764-0.844),Hosmer-Lemeshow 检验表明该列线图具有良好的校准度(P=0.288)。我们的列线图在内部验证队列中也表现出良好的区分能力和校准度。我们的列线图在识别 ICU 中发生 SCM 风险增加的患者方面具有良好的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/14f1d3ae1d77/41598_2024_64965_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/94782dae93fb/41598_2024_64965_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/1a5f81fdd143/41598_2024_64965_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/b9da80df17aa/41598_2024_64965_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/9bd1d7f9936b/41598_2024_64965_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/46637fe9d4a2/41598_2024_64965_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/14f1d3ae1d77/41598_2024_64965_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/94782dae93fb/41598_2024_64965_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/1a5f81fdd143/41598_2024_64965_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/b9da80df17aa/41598_2024_64965_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/9bd1d7f9936b/41598_2024_64965_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/46637fe9d4a2/41598_2024_64965_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5305/11187202/14f1d3ae1d77/41598_2024_64965_Fig6_HTML.jpg

相似文献

1
Development and validation of a nomogram to predict risk of septic cardiomyopathy in the intensive care unit.开发和验证一种列线图,以预测重症监护病房中脓毒症性心肌病的风险。
Sci Rep. 2024 Jun 19;14(1):14114. doi: 10.1038/s41598-024-64965-x.
2
[Development and validation of a prognostic model for patients with sepsis in intensive care unit].[重症监护病房脓毒症患者预后模型的开发与验证]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Aug;35(8):800-806. doi: 10.3760/cma.j.cn121430-20230103-00003.
3
[Construction and validation of a risk nomogram for sepsis-associated acute kidney injury in intensive care unit].[重症监护病房中脓毒症相关性急性肾损伤风险列线图的构建与验证]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Aug;36(8):801-807. doi: 10.3760/cma.j.cn121430-20240221-00150.
4
[Analysis of 28 day-mortality risk factors in sepsis patients and construction and validation of predictive model].[脓毒症患者28天死亡风险因素分析及预测模型的构建与验证]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 May;36(5):478-484. doi: 10.3760/cma.j.cn121430-20231109-00961.
5
Nomogram predictive model for in-hospital mortality risk in elderly ICU patients with urosepsis.老年脓毒症性泌尿系统感染重症监护病房患者院内死亡风险的列线图预测模型
BMC Infect Dis. 2024 Apr 26;24(1):442. doi: 10.1186/s12879-024-09319-8.
6
[Development and validation of a nomogram for predicting 3-month mortality risk in patients with sepsis-associated acute kidney injury].[用于预测脓毒症相关性急性肾损伤患者3个月死亡风险的列线图的开发与验证]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 May;36(5):465-470. doi: 10.3760/cma.j.cn121430-20231218-01091.
7
[Construction and validation of a predictive model for early occurrence of lower extremity deep venous thrombosis in ICU patients with sepsis].[脓毒症重症监护病房患者下肢深静脉血栓形成早期发生预测模型的构建与验证]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 May;36(5):471-477. doi: 10.3760/cma.j.cn121430-20231117-00985.
8
Risk factors of postoperative septic cardiomyopathy in perioperative sepsis patients.围手术期脓毒症患者术后感染性心肌病的危险因素。
BMC Anesthesiol. 2022 Jun 22;22(1):193. doi: 10.1186/s12871-022-01714-5.
9
Development and Internal Validation of a Nomogram to Predict Mortality During the ICU Stay of Thoracic Fracture Patients Without Neurological Compromise: An Analysis of the MIMIC-III Clinical Database.开发并内部验证了一种列线图,用于预测无神经功能障碍的胸骨折患者 ICU 住院期间的死亡率:对 MIMIC-III 临床数据库的分析。
Front Public Health. 2021 Dec 22;9:818439. doi: 10.3389/fpubh.2021.818439. eCollection 2021.
10
Nomogram to predict the risk of acute kidney injury in patients with diabetic ketoacidosis: an analysis of the MIMIC-III database.预测糖尿病酮症酸中毒患者急性肾损伤风险的列线图:对 MIMIC-III 数据库的分析。
BMC Endocr Disord. 2021 Mar 4;21(1):37. doi: 10.1186/s12902-021-00696-8.

引用本文的文献

1
Development and validation of a nomogram to predict survival in septic patients with heart failure in the intensive care unit.用于预测重症监护病房中合并心力衰竭的脓毒症患者生存率的列线图的开发与验证
Sci Rep. 2025 Jan 6;15(1):909. doi: 10.1038/s41598-025-85596-w.

本文引用的文献

1
Relationship between 24 h blood pressure variability and mortality in acute myocardial infarction patients.24 小时血压变异性与急性心肌梗死患者死亡率的关系。
Clin Cardiol. 2024 Apr;47(4):e24261. doi: 10.1002/clc.24261.
2
MIMIC-IV, a freely accessible electronic health record dataset.MIMIC-IV,一个可自由访问的电子健康记录数据集。
Sci Data. 2023 Jan 3;10(1):1. doi: 10.1038/s41597-022-01899-x.
3
Progress in the Clinical Assessment and Treatment of Myocardial Depression in Critically Ill Patient with Sepsis.脓毒症重症患者心肌抑制的临床评估与治疗进展
J Inflamm Res. 2022 Sep 20;15:5483-5490. doi: 10.2147/JIR.S379905. eCollection 2022.
4
The Effect of Sepsis on Myocardial Function: A Review of Pathophysiology, Diagnostic Criteria, and Treatment.脓毒症对心肌功能的影响:病理生理学、诊断标准及治疗的综述
Cureus. 2022 Jun 21;14(6):e26178. doi: 10.7759/cureus.26178. eCollection 2022 Jun.
5
MIMIC-IV as a Clinical Data Schema.MIMIC-IV 作为一种临床数据模式。
Stud Health Technol Inform. 2022 May 25;294:559-560. doi: 10.3233/SHTI220522.
6
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e876-e894. doi: 10.1161/CIR.0000000000001062. Epub 2022 Apr 1.
7
Pathogenetic mechanisms of septic cardiomyopathy.脓毒症性心肌病的发病机制
J Cell Physiol. 2022 Jan;237(1):49-58. doi: 10.1002/jcp.30527. Epub 2021 Jul 18.
8
Septic Cardiomyopathy: From Basics to Management Choices.脓毒症性心肌病:从基础到治疗选择。
Curr Probl Cardiol. 2021 Apr;46(4):100767. doi: 10.1016/j.cpcardiol.2020.100767. Epub 2020 Dec 11.
9
Sepsis-Induced Cardiomyopathy: a Comprehensive Review.脓毒症相关性心肌病:全面综述。
Curr Cardiol Rep. 2020 May 6;22(5):35. doi: 10.1007/s11886-020-01277-2.
10
Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress.脓毒症性心肌病的现状:基础科学与临床进展
Front Pharmacol. 2020 Mar 3;11:210. doi: 10.3389/fphar.2020.00210. eCollection 2020.